2m 2m 2m 2m 2m 2m 2m
Fortrea (FTRE)
NASDAQ
$16.41+$0.85 (+5.43%)
Price as of Jun 23, 2026 5:15 PM EDT- $1.5BMarket Cap
- 205.10%1-Year Change
- BiotechnologyIndustry
Fortrea (FTRE)
$16.41+$0.85 (+5.43%)
FTRE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $15.56 | ||
Change | +$0.25 (+1.63%) | ||
Open | $15.69 | ||
High | $15.99 | ||
Low | $15.20 | ||
Previous Close | $15.31 | ||
Volume | 1,727,449 | ||
30-Day Average Volume | 1,428,551 | ||
1-Week Change | -6.43% | ||
1-Month Change | 17.70% | ||
1-Year Change | 205.10% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 94.6M | ||
Total Assets | $2.7B | ||
Market Cap | $1.5B | ||
Enterprise Value | $2.4B | ||
Period: QTR TTM FY | |||
Revenue | $636.5M | ||
Net Income | -$23.6M | ||
Free Cash Flow | -$25.0M | ||
EBIT | $6.8M | ||
EBITDA | $26.6M | ||
Net Working Capital | -$47.6M | ||
EPS | -$0.25 | ||
Enterprise Value/EBITDA | 89 | ||
Enterprise Value/Revenue | 4 | ||
P/B | 3 | ||
P/E | -62 | ||
PEG | -2 | ||
Price/Free Cash Flow | -59 | ||
Price/Operating Cash Flow | -87 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue